Report: N.J. Doctor Tipped Martoma

Sep 6 2013 | 11:43am ET

A prominent New Jersey Alzheimer's disease doctor passed confidential information to a former SAC Capital Advisors portfolio manager, according to published reports.

Joel Ross is the man identified as "Doctor-2" in the revised indictment against Mathew Martoma, unsealed late last month. Unlike Martoma's other alleged source for tips about Alzheimer's drug trials, Ross has not been accused of any wrongdoing.

Ross is the founder of the Memory Enhancement Center in Eatontown, N.J., a clinical professor at the Mt. Sinai School of Medicine and a proponent of the use of experimental medicines to treat Alzheimer's. As with Sidney Gilman, the former University of Michigan medical professor who has admitted to passing Martoma tips, Martoma met Ross through an expert-networking firm which was not indentified.

And as with Gilman, Martoma's alleged primary interest with Ross was bapineuzumab, an Alzheimer's drug being developed by Elan Corp. and Wyeth LLC. Martoma is accused of illegally-trading shares of those company, earning or saving SAC a combined $276 million; the allegations are also at the heart of the criminal insider-trading case against SAC.

According to the indictment, Ross gave Martoma confidential information about drug trials, including those into bapineuzumab. The two men also met after Ross was briefed on those trial results.

In exchange, the indictment alleges, Martoma "would assist Doctor-2 in obtaining additional clinical trial business." Ross' identity was first reported by The Wall Street Journal.

Martoma has pleaded not guilty and refused to cooperate with prosecutors; he is set to face trial beginning Nov. 4.


In Depth

Q&A: Executive Recruiter Talks Hedge Fund Closures, Hiring Trends

Dec 19 2014 | 6:58am ET

This year, hedge funds have been closing at a rate not seen since the financial...

Lifestyle

Cooper-Hohn Won't Contest Divorce Settlement

Dec 18 2014 | 9:51am ET

The ex-wife of hedge fund billionaire Christopher Hohn will not contest a divorce...

Guest Contributor

Alternative Investment Funds Face A Communications Imperative

Dec 19 2014 | 6:10am ET

A handful of the top alternative investment firms on both sides of the Atlantic...

 

Sponsored Content

Editor's Note

    Guidelines for Guest Articles

    Oct 22 2014 | 9:46am ET

    We are always looking for guest articles from hedge fund managers and buy-side firms.

    If you are interested in submitting a contributed piece for possible publication on FINalternatives, please take a look at the specs. Read more…

 

Futures Magazine

December 2014 Cover

Futures 2014 person of the year

Jeff Sprecher was simply looking for a platform to trade energies when launching ICE 14 years ago but it has grown to reach the pinnacle of both the listed futures and equities world.

The Alpha Pages

TAP July/August 2014 Cover

The Alpha Pages Interview: Senator Rand Paul

Senator Paul sat down in the debut series of the Alpha Pages Interview to discuss the broken tax code, regulation surrounding Bitcoin, and his plans for the 2016 Presidential election.